Cornelis J H van de Velde Selected Research

exemestane (Aromasin)

1/2021	The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
1/2020	Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer.
1/2019	Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
1/2017	Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
4/2016	The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis.
1/2016	Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.
3/2015	Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.
9/2014	Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
9/2014	Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trial.
4/2014	External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelis J H van de Velde Research Topics

Disease

131	Neoplasms (Cancer) 06/2022 - 01/2002
74	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2002
65	Rectal Neoplasms (Rectal Cancer) 02/2022 - 03/2002
41	Colorectal Neoplasms (Colorectal Cancer) 06/2019 - 05/2002
36	Stomach Neoplasms (Stomach Cancer) 06/2022 - 08/2002
33	Neoplasm Metastasis (Metastasis) 09/2021 - 07/2002
17	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2004
13	Carcinoma (Carcinomatosis) 10/2015 - 03/2002
9	Adenocarcinoma 01/2021 - 08/2002
7	Margins of Excision 08/2011 - 05/2007
4	Uveal melanoma 12/2016 - 02/2004
3	Neoplasm Micrometastasis 11/2016 - 12/2005
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 11/2011
3	Lymphatic Metastasis 05/2011 - 12/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016 - 01/2013
2	Adenoma (Adenomas) 09/2016 - 11/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2015
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 11/2015 - 06/2014
2	Vulvar Neoplasms (Vulvar Cancer) 12/2014 - 01/2012
2	Carcinogenesis 07/2014 - 06/2002

Drug/Important Bio-Agent (IBA)

28	Hormones (Hormone)IBA 07/2021 - 01/2007
22	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2007
19	Tamoxifen FDA LinkGeneric 01/2021 - 01/2009
19	exemestane (Aromasin)FDA Link 01/2021 - 01/2011
15	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2002
15	ParaffinIBA 01/2021 - 08/2002
13	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 05/2011
11	Proteins (Proteins, Gene)FDA Link 03/2019 - 01/2002
10	Formaldehyde (Formol)FDA Link 01/2021 - 05/2005
8	Estrogen ReceptorsIBA 01/2022 - 01/2007
8	Melphalan (Alkeran)FDA LinkGeneric 12/2016 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 05/2010
6	Capecitabine (Xeloda)FDA Link 01/2020 - 05/2010
6	Monoclonal AntibodiesIBA 11/2019 - 05/2004
6	Peptides (Polypeptides)IBA 03/2017 - 01/2004
6	HLA Antigens (Human Leukocyte Antigens)IBA 09/2016 - 10/2006
6	EnzymesIBA 11/2014 - 07/2002
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2002
5	HLA-G Antigens (HLA G)IBA 01/2018 - 12/2010
5	VaccinesIBA 04/2013 - 05/2002
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2022 - 05/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2007
4	Letrozole (Femara)FDA LinkGeneric 01/2021 - 01/2018
4	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 05/2009
4	AntibodiesIBA 11/2019 - 12/2008
4	Carcinoembryonic AntigenIBA 10/2018 - 10/2015
4	Aromatase InhibitorsIBA 01/2018 - 01/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 12/2012
4	Contrast MediaIBA 09/2016 - 07/2010
4	Methylene Blue (Methylthioninium Chloride)FDA Link 11/2015 - 07/2012
4	Histones (Histone)IBA 05/2015 - 01/2014
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2014 - 05/2007
4	Biological ProductsIBA 01/2014 - 05/2008
4	Human Serum Albumin FDA LinkGeneric 01/2013 - 11/2011
3	Estrogens (Estrogen)FDA Link 01/2021 - 04/2016
3	Epithelial Cell Adhesion MoleculeIBA 03/2019 - 02/2007
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2007
3	IntegrinsIBA 03/2017 - 12/2014
3	Pharmaceutical PreparationsIBA 01/2017 - 02/2014
3	Urokinase Plasminogen Activator ReceptorsIBA 12/2016 - 01/2011
3	EpitopesIBA 09/2016 - 04/2004
3	Folate Receptor 1IBA 05/2016 - 01/2016
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2015 - 01/2011
3	AntigensIBA 05/2014 - 05/2002
3	HLA-A Antigens (HLA-A)IBA 10/2006 - 01/2004
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 09/2005
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 09/2005
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2019
2	Immunoglobulin FragmentsIBA 03/2019 - 10/2015
2	ElementsIBA 12/2018 - 08/2012
2	LigandsIBA 01/2016 - 01/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 10/2008
2	Sirtuin 1IBA 01/2015 - 08/2014
2	Coloring Agents (Dyes)IBA 12/2014 - 07/2013
2	Phenobarbital (Luminal)FDA Link 07/2014 - 06/2011
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2014 - 05/2007
2	Keratins (Keratin)IBA 09/2013 - 05/2011
2	AlbuminsIBA 05/2013 - 05/2011
2	InterferonsIBA 04/2013 - 09/2007
2	NucleotidesIBA 12/2011 - 12/2003

Therapy/Procedure

58	Radiotherapy 02/2022 - 03/2002
57	Therapeutics 01/2022 - 03/2002
37	Drug Therapy (Chemotherapy) 06/2022 - 04/2002
20	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 03/2004
19	Adjuvant Chemotherapy 01/2021 - 01/2007
16	Neoadjuvant Therapy 01/2022 - 06/2009
13	Chemoradiotherapy 01/2022 - 05/2010
7	Gastrectomy 12/2019 - 12/2005
6	Immunotherapy 06/2019 - 01/2004
5	Segmental Mastectomy (Lumpectomy) 01/2018 - 08/2011
4	Computer-Assisted Surgery (Image Guided Surgery) 11/2019 - 04/2011
4	Aftercare (After-Treatment) 01/2016 - 02/2004
4	Proctectomy 06/2013 - 07/2007
3	Lasers (Laser) 01/2015 - 10/2005
2	Induction Chemotherapy 12/2019 - 12/2018
2	Mastectomy (Mammectomy) 01/2018 - 01/2018
2	Operative Surgical Procedures 01/2018 - 05/2009
2	Cytoreduction Surgical Procedures 01/2016 - 01/2015
2	Intravenous Administration 01/2015 - 07/2003
2	Adjuvant Chemoradiotherapy 01/2012 - 12/2005